Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain
Clinical trial NCT03898908 · COMPLETED
Trial details
- NCT number
- NCT03898908
- Sponsor
- Grupo Español Multidisciplinar de Melanoma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-18
- Primary completion
- 2022-10-10
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.